Diabetes drugs' use for weight loss risky: Doctors

A study published recently in the Journal of American Medical Association (JAMA), also points to this. This study found that use of GLP-1 agonists for weight loss compared with use of other weight-loss drugs was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction, but not biliary disease.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/JLYDVHr
via